NewsRoom Articles - Page 170 of 214

FridayMar 19, 2021 12:41 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Remains on Schedule to bring in Bladder Cancer Imaging System to Market

Bladder cancer is the fourth most common cancer in men andexpected to cause more than 17,000 deaths in the United States this year Imagin Medical is advancing its patented bladder cancer visualization technology toward commercialization and FDA approval, expecting the technology to revolutionize blue light cystoscopy procedures and improve patient outcomes in the process Imagin is funding its efforts with $2.165 million raised towards its convertible note offering Rollout of the company’s manufacturing process was delayed about nine months as a result of the COVID-19 pandemic.but Imagin and its production partner remain on its revised schedule The company expects to…

ThursdayMar 18, 2021 1:00 pm

Lessons from the Fight Against COVID-19

The coronavirus pandemic has affected various sectors of the economy, with the health-care sector being the most overwhelmed. The public health and economic burdens that the pandemic has caused call for us to reevaluate our approach to developing new therapies and vaccines. In an attempt to gather what can be applied to research and development in the future, we look at a few useful lessons that health-care researchers can gain from this pandemic experience. At the onset of the pandemic, there was a lot about the coronavirus that was unknown. We observed many organizations working together to learn more about…

ThursdayMar 18, 2021 12:35 pm

Healthy Extracts Inc. (HYEX) Focuses on Growth in 2021, Reaching a Potential Market of 200 Million People

Company reports positive clinical results from HERHEART(TM) and Fuel4Thought(TM), produced by subsidiaries BergaMet North America and Ultimate Brain Nutrients Purchase agreement with Xymogen(R) for BergaMet North America’s Citrus Bergamot SuperFruit(TM) expected to generate significant revenue and distribution opportunities nationwide The global market for botanical and plant-derived drugs was valued at $29.4 billion in 2017 and is expected to reach $39.6 billion by 2022 Healthy Extracts is nearly debt-free with minimal overhead costs Through a growing portfolio of wholly owned subsidiaries, Healthy Extracts (OTCQB: HYEX) (formerly Grey Cloak Tech) is engaged in proprietary research and development of natural plant-based formulations, sales, and distribution…

WednesdayMar 17, 2021 3:15 pm

University of Louisiana-Monroe to Launch Biomedical Research Park with Partners

Several economic development figures and public officials recently established a research park to help attract science, technology and biomedical companies to Monroe, Louisiana. The not-for-profit organization launched the Biomedical Research and Innovation Park, which would collaborate with the University of Louisiana-Monroe and would inhabit a proposed facility near the institution’s College of Pharmacy facility. Monroe’s Dr. Ray Armstrong, who was the lead in the creation of the research park, stated that the park would not only focus on biomedical research but that its objective would be to encourage innovation in every field and promote economic development throughout Northeast Louisiana. University…

WednesdayMar 17, 2021 2:01 pm

Imagin Medical (CSE: IME) (OTCQB: IMEXF), With Their Advanced i/Blue(TM) Imaging System, Closes Second Tranche of Convertible Note Offering

Imagin Medical is a surgical company focused on developing its i/Blue(TM) Imaging System, employing patented ultrasensitive imaging technology The i/Blue(TM) Imaging System is system compatible; system attaches to most endoscopes The company recently closed the second tranche for the amount of US$1,415,500 of the Convertible Note offering Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive surgical procedures. Imagin Medical is run by an experienced management team that is preparing their i/Blue(TM) Imaging System for the industry. An FDA approval process is underway. The company’s patented ultrasensitive…

TuesdayMar 16, 2021 2:36 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Brain cancer drug developer CNS Pharmaceuticals is finalizing preparations to begin March enrollment of patients in its potentially pivotal Phase 2 trial evaluating its promising lead candidate, Berubicin, for the overall survival improvement of glioblastoma (“GBM”) patients Glioblastomas are a type of brain cancer that have continued to elude effective therapy over the past century of investigation, leaving patients with expectations of approximately 15 months of survivability beyond diagnosis and recurrence after surgical removal A GBM patient in a small Phase 1 Berubicin safety trial 15 years ago has remained cancer-free and stable as of last November, a hint of…

MondayMar 15, 2021 3:15 pm

Washington University Awarded $3.1 Million Grant for ALS Research

The National Institute of Neurological Disorders and Stroke, which is a National Institutes of Health affiliate, recently awarded researchers from St. Jude Children’s Research Hospital and Washington University in St. Louis a $3.1 million grant. Tanja Mittag, of the Department of Structural Biology at St. Jude and Washington University’s Rohit Pappu, who is an engineering professor in the McKelvey School of Engineering, collected the funds, which would enable the team to research RNA-binding proteins that mutate in individuals with genetic forms of Lou Gehrig’s disease, also referred to as amyotrophic lateral sclerosis. The objective is to discover the basic process…

MondayMar 15, 2021 2:16 pm

Healthy Extracts Inc. (HYEX) Reports 71% Revenue Increase Backed by Industry Momentum

Healthy Extracts Inc. officially changed its name from Grey Cloak Tech Inc. on March 1, formalizing the company’s shift into the health products industry Healthy Extracts currently wholly owns two subsidiaries, BergaMet North America (“NA”) and Ultimate Brain Nutrients (“UBN”), and reported a revenue increase of 71% from $748,377 in 2019 to $1,276,559 in the 12 months ending December 31, 2020 This revenue growth is consistent with the trend in the plant-based foods and products industry, which is growing due to increased health consciousness and concerns regarding climate change The plant-based foods and products industry is experiencing a boom attributable…

MondayMar 15, 2021 12:18 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Revolutionary Technology a Cost Saver for Hospitals and Patients

White light cystoscopy (“WLC”) is the most commonly used procedure to detect non-muscle invasive bladder cancer (“NMIBC”) Despite its prevalence, WLC is not the most effective method and contributes to a high bladder cancer recurrence rate Blue light cystoscopy (“BLC”) is a more recent and highly effective method, but the high cost of equipment and skill level has impeded its uptake among hospitals Imagin Medical believes the i/Blue(TM) Imaging System , which displays white and blue light images side by side, will address these issues It eliminates the need to purchase new cystoscopes. The i/Blue System’s dual-view camera head can…

FridayMar 12, 2021 3:15 pm

Engineers at Buffalo University Close to Using 3D Printing to Make Human Organs

Engineers from the University at Buffalo have designed a technology that allows 3D-printed human organs and tissues to be developed at a pace that is almost 50 times faster than the current industry standard. This biotechnology could be used to save lives that may have otherwise been lost due to donor organ shortages. Associate professor of biomedical engineering and the co-lead author of the study Ruogang Zhao explained that the technology also worked with big sample sizes, which was not easy to achieve prior to the technology’s invention. The study was reported in the “Advanced Healthcare Materials” journal in February.…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Remains on Schedule to bring in Bladder Cancer Imaging System to Market

Lessons from the Fight Against COVID-19

Healthy Extracts Inc. (HYEX) Focuses on Growth in 2021, Reaching a Potential Market of 200 Million People

University of Louisiana-Monroe to Launch Biomedical Research Park with Partners

Imagin Medical (CSE: IME) (OTCQB: IMEXF), With Their Advanced i/Blue(TM) Imaging System, Closes Second Tranche of Convertible Note Offering

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Washington University Awarded $3.1 Million Grant for ALS Research

Healthy Extracts Inc. (HYEX) Reports 71% Revenue Increase Backed by Industry Momentum

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Revolutionary Technology a Cost Saver for Hospitals and Patients

Engineers at Buffalo University Close to Using 3D Printing to Make Human Organs

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search